Small Molecules
9 October 2014
GenSpera Announces Completion of Patient Enrollment in the Phase II Clinical Trial of Mipsagargin in Liver Cancer Patients9 October 2014
Shire Provides Regulatory Update on SHP 465, Investigational Compound for ADHD in Adults8 October 2014
Ruthigen Initiates Phase 1/2 Clinical Trial of RUT58-608 October 2014
FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis8 October 2014
PharmaEngine, Nanobiotix Enter Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma7 October 2014
FDA Grants Clearance to Proceed with Clinical Study – New Drug Candidate from Vivolux Could Overcome Drug Resistance7 October 2014
Cavion and Yale University Announce First Patient Enrolled in Phase 1b Clinical Trial in Brain Cancer7 October 2014
Phosphagenics Announces Successful Results from its Phase 2 TPM/Tretinoin Gel Study on Acne Patients7 October 2014
Acacia Pharma Announces Positive Phase 3 Results For APD421 in Post-Operative Nausea & Vomiting (PONV)7 October 2014
Tetraphase Pharmaceuticals Announces Initiation of Pivotal Portion of IGNITE 2 Phase 3 Trial of Eravacycline in cUTI6 October 2014
Foamix Pharmaceuticals Ltd. Announces Initiation of Phase II Trial With FDX104 in Chemotherapy Induced Rash3 October 2014
Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study3 October 2014
NeurOp Receives Milestone Payment as Bristol-Myers Squibb Nominates NMDA Receptor Compound as Drug Development Candidate2 October 2014
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib2 October 2014
Tobira Therapeutics’ Cenicriviroc Shows Improvement in Liver Fibrosis Scores in Phase 2b Study to be Presented at AASLD1 October 2014
IntelGenx and RedHill Biopharma Submit European Marketing Authorization Application for Migraine Drug RIZAPORTNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports